Literature DB >> 26617728

FBXW12, a novel F box protein-encoding gene, is deleted or methylated in some cases of epithelial ovarian cancer.

Elsa De La Chesnaye1, Juan Pablo Méndez2, Ricardo López-Romero3, María De Los Angeles Romero-Tlalolini1, María Dolores Vergara4, Mauricio Salcedo3, Sergio R Ojeda5.   

Abstract

Epithelial ovarian cancer is one of the most lethal of gynecological malignancies. Due to its lack of early symptoms, detection usually occurs when the tumor is no longer confined to the ovary. We previously identified Fbxw15, a gene encoding an F-box protein in the mouse ovary, and showed that its expression is developmentally regulated. Here we report the molecular analysis of its human homologue, FBXW12 in epithelial ovarian tumors. To search for FBXW12 gene mutations, we PCR-amplified and sequenced the coding region of FBXW12, the gene's 5-untranslated region and the proximal promoter in each of 30 EOC tumors. Promoter methylation was determined by DNA bisulfite conversion, followed by methylation specific PCR. FBXW12 intracellular localization was identified by means of immunohistochemistry. A complete deletion of the gene's coding region, the 5'-UTR and the proximal promoter, was observed in 3 EOC samples. Eight of the remaining 27, had a deletion of the 5'-UTR, and the proximal promoter. FBXW12 mRNA was detected in 2 of the 19 samples without deletions. The methylation specific PCR results demonstrated CpGs methylation in the FBXW12 proximal promoter. Immunohistochemistry assay revealed that within the normal ovary, FBXW12 has an oocyte specific expression, whereas in EOC samples it is present in the ovarian surface epithelium. Our results indicate that the FBXW12 gene is deleted in approximately ten percent of the EOC cases studied; such deletions comprised either the FBXW12 promoter or the mRNA-encoding region. Moreover, FBXW12 could be epigenetically silenced by CpGs methylation in some of these EOC cases.

Entities:  

Keywords:  F-box proteins; epithelial ovarian cancer

Mesh:

Substances:

Year:  2015        PMID: 26617728      PMCID: PMC4637543     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  38 in total

1.  Regulator of myeloid differentiation and function: The secret life of Ikaros.

Authors:  Olivia L Francis; Jonathon L Payne; Rui-Jun Su; Kimberly J Payne
Journal:  World J Biol Chem       Date:  2011-06-26

2.  MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

Authors:  Nuo Yang; Sippy Kaur; Stefano Volinia; Joel Greshock; Heini Lassus; Kosei Hasegawa; Shun Liang; Arto Leminen; Shan Deng; Lori Smith; Cameron N Johnstone; Xian-Ming Chen; Chang-Gong Liu; Qihong Huang; Dionyssios Katsaros; George Adrian Calin; Barbara L Weber; Ralf Bützow; Carlo M Croce; George Coukos; Lin Zhang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

3.  Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma.

Authors:  Ines Gütgemann; Norman L Lehman; Peter K Jackson; Teri A Longacre
Journal:  Mod Pathol       Date:  2008-01-18       Impact factor: 7.842

Review 4.  Minireview: epigenetic changes in ovarian cancer.

Authors:  Curt Balch; Fang Fang; Daniela E Matei; Tim H-M Huang; Kenneth P Nephew
Journal:  Endocrinology       Date:  2009-07-02       Impact factor: 4.736

5.  Fbxw15/Fbxo12J is an F-box protein-encoding gene selectively expressed in oocytes of the mouse ovary.

Authors:  Elsa De La Chesnaye; Bredford Kerr; Alfonso Paredes; Horacio Merchant-Larios; Juan Pablo Méndez; Sergio R Ojeda
Journal:  Biol Reprod       Date:  2007-12-19       Impact factor: 4.285

6.  Ovarian carcinoma develops through multiple modes of chromosomal evolution.

Authors:  Mattias Höglund; David Gisselsson; Gunnar B Hansen; Torbjörn Säll; Felix Mitelman
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

7.  Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.

Authors:  Tatiana Y Prudnikova; Nikolaos Soulitzis; Olesya S Kutsenko; Lyudmila A Mostovich; Klas Haraldson; Ingemar Ernberg; Vladimir I Kashuba; Demetrios A Spandidos; Eugene R Zabarovsky; Elvira V Grigorieva
Journal:  Cancer Med       Date:  2013-08-05       Impact factor: 4.452

8.  Chromosomal rearrangements and their relations to histopathological and clinical parameters in epithelial ovarian cancer.

Authors:  N Jancarková; M Krkavcová; M Janashia; P Freitag; J Dusková; D Cibula
Journal:  Folia Biol (Praha)       Date:  2008       Impact factor: 0.906

9.  Epithelial ovarian cancer: the role of cell cycle genes in the different histotypes.

Authors:  Giuseppina D'Andrilli; Antonio Giordano; Alessandro Bovicelli
Journal:  Open Clin Cancer J       Date:  2008-02-06

10.  High expression of octamer transcription factor 1 in cervical cancer.

Authors:  Songshu Xiao; Shan Liao; Yanhong Zhou; Bin Jiang; Yueran Li; Min Xue
Journal:  Oncol Lett       Date:  2014-04-02       Impact factor: 2.967

View more
  4 in total

Review 1.  Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.

Authors:  Nana Zheng; Zhiwei Wang; Wenyi Wei
Journal:  Int J Biochem Cell Biol       Date:  2016-02-06       Impact factor: 5.085

Review 2.  Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Authors:  Nana Zheng; Quansheng Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-05-05

Review 3.  Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.

Authors:  Sang-Min Jang; Christophe E Redon; Mirit I Aladjem
Journal:  Front Mol Biosci       Date:  2018-03-13

4.  FBXW7 inhibits invasion, migration and angiogenesis in ovarian cancer cells by suppressing VEGF expression through inactivation of β-catenin signaling.

Authors:  Liping Zhong; Yuefen Pan; Junjun Shen
Journal:  Exp Ther Med       Date:  2021-03-19       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.